Heinz Wiendl

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

Xavier Montalbán, Ralf Gold, Alan J. Thompson et al. · Multiple Sclerosis Journal · 2018 · 705 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +12

Ofatumumab versus Teriflunomide in Multiple Sclerosis

Stephen L. Hauser, Amit Bar‐Or, Jeffrey Cohen et al. · New England Journal of Medicine · 2020 · 700 citations · Full text

Life Sciences, Immunology, Pharmacology +17

How patients with multiple sclerosis acquire disability

Fred Lublin, Dieter A. Häring, Habib Ganjgahi et al. · Brain · 2022 · 528 citations · Full text

Education, Neurology, Disability Management +13

Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis

David Schafflick, Chenling Xu, Maike Hartlehnert et al. · Nature Communications · 2020 · 454 citations · Full text

Life Sciences, Immunology, Neuroscience +17